Medical Health Cluster


Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19A Meta-analysis

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Article Information Key PointsQuestion  Is administration of IL-6 antagonists associated with 28-day all-cause mortality in patients hospitalized for COVID-19?Findings  This prospective meta-analysis of 27 randomized trials included 10 930 patients, of whom 2565 died by 28 days. The 28-day all-cause mortality was […]

Read More